Arcturus Therapeutics Holdings (ARCT) FCF Margin Growth (3y) (2021 - 2026)
Powered by 
Analysis
Arcturus Therapeutics Holdings (ARCT) FCF Margin Growth (3y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -1,272.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -2,228.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -5,426.00 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 9,545.00 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 4,612.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -3,088.00 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 14,060.00 |
| 10 | Arcturus Therapeutics Holdings | 449.65 Mn | 258.17 Mn | - | -115,250.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -115,250.00 |
| Mar 31, 2026 | -89,774.00 |
| Dec 31, 2025 | -32,188.00 |
| Sep 30, 2025 | 22,949.00 |
| Jun 30, 2025 | 11,566.00 |
| Mar 31, 2025 | 85,534.00 |
| Dec 31, 2024 | 75,151.00 |
| Sep 30, 2024 | 69,859.00 |
| Jun 30, 2024 | 159,941.00 |
| Mar 31, 2024 | 201,521.00 |
| Dec 31, 2023 | 32,261.00 |
| Sep 30, 2023 | 62,518.00 |
| Jun 30, 2023 | 86,047.00 |
| Mar 31, 2023 | 41,251.00 |
| Dec 31, 2022 | 36,219.00 |
| Sep 30, 2022 | -24,028.00 |
| Jun 30, 2022 | -22,592.00 |
| Mar 31, 2022 | -84,791.00 |
| Dec 31, 2021 | -67,373.00 |
| Sep 30, 2021 | -54,991.00 |